Salicylate gel restrictions

The Medicines and Healthcare products Regulatory Agency (MHRA) has advised that topical oral pain relief gels containing salicylate salts should be contraindicated in children under 16 years.

The restrictions are a precautionary measure only to remove the theoretical risk of Reye’s syndrome in children.

The new advice from new advice for topical oral salicylate products brings them in line with other oral salicylate containing products.

The products affected by this advice include Bonjela, Bonjela Cool Mint and Pyralvex. The advice does not affect Bonjela Teething Gel, as it does not contain salicylates.

Further information: MHRA letter to healthcare professionals

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases